MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / Health & Medical News / Diabetes / Older Type 2 Diabetes Drugs Work Well

Older Type 2 Diabetes Drugs Work Well

July 18, 2007 By MedNews 1 Comment

While new diabetes drugs have been introduced on the market, recent studies have found that the older drugs, such as second generation sulfonylureas and metformin (sold under the brand names Glucophage, Diabex, Diaformin, Fortamet, Riomet, Glumetza, and others) work just fine in controlling blood glucose for most patients.

These older drugs are less expensive, and, according to researchers, a drug such as Metformin appears to have the best benefit, particularly when risk is accounted for.

Metformin was first approved by the FDA for diabetes treatment in 1994 and marketed in the United States for diabetes treatment in 1995 by Bristol Myers Squibb under the brand name Glucophage.

The study did not examine the effectiveness of the most recent class of anti-diabetes drugs called incretin mimetics, such as exenatide (Byetta) and sitagliptin (Januvia).

Filed Under: Diabetes Tagged With: byetta, Diabetes, Diabex, Diaformin, exenatide, Fortamet, glucophage, Glumetza, januvia, metformin, Riomet, sitagliptin



Comments

  1. walter says

    July 20, 2007 at 12:13 am

    I think this is true with a lot of new drugs. There’s so much money to be made for a new drug, or a new use of an old drug, that pharma companies really push an incremental benefit in order to get something approved as new, which they can then sell exclusively without competition for a period of years.

    However, not only are the new drugs often much more costly, but their benefits are often just slightly better (if at all), and that’s without considering the negative side effects, which for new drugs is not always apparent until after several years of use.

    Personally, I would not take a new drug until it’s been on the market for a while.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol alzheimers asthma breast cancer cancer children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause mrsa NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun swine flu teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2023 Mednews · Log in